Phenylpropanoid saccharide esters, methods and uses thereof

Patent number:

EP3938374

Portugal.svg
No items found.

The present disclosure relates to phenylpropanoid saccharide esters, methods for the synthesis of libraries of phenylpropanoid saccharide esters with different degree and place of substitution in the sugar core, and their use as antimicrobial agents, cytotoxic agents and/or antitumoral agents. The present disclosure relates to a compound for formula I wherein R1, R2, R3 and R4 are independently selected from each other; R1 is selected from H or COCH3, R2, R3 and R4 is selected from H, OCH3, OH, for use in a method for the treatment of a microbial infection, or for use in a method for the treatment of a fungal infection or for use in a method for the treatment of cancer.

Countries:
Portugal
Regions:
No items found.
Centers:
UNIVERSIDADE NOVA DE LISBOA
Other entities:
Sectors:
Chemicals
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The present disclosure relates to phenylpropanoid saccharide esters, methods for the synthesis of libraries of phenylpropanoid saccharide esters with different degree and place of substitution in the sugar core, and their use as antimicrobial agents, cytotoxic agents and/or antitumoral agents. The sim- plest sucrose ester is the 6-O-cinnamoyl sucrose ester, known under the trivial name Sibirioside A. Herein, it was synthesized for the first time in only one step from sucrose and cinnamic acid applying chemose- lective procedure. The chemical structure of the synthesized sucrose ester and its unnatural analogue were con- firmed by optical rotation, m.p., NMR, and mass spectra. Their antibacterial, antifungal, cytotoxic and antioxidant activities were investigated. They exhibited strong inhibition against all bacteria tested, namely Staphylococcus aureus, Bacillus cereus, Micrococcus flavus, Listeria monocytogenes, Pseudomo nas aeruginosa, Salmonella typhimurium, Escherichia coli and Enterobacter cloacae and strong antifungal activity towards Aspergillus versicolor, Aspergillus ochraceus, Trichoderma viride and Penicillium ochro- chloron. They showed moderate antioxidant and antitumor potential against human breast, colon and cervical cell lines without hepatotoxicity. The phenylpropanoid saccharide esters now disclosed can be obtained in larger quantities and at cheaper price comparing to the extracted one and thus could find application in various pharmacolog- ical compositions.

Comments

Other related patents

Health

NEW MICROEXTRACTION DEVICE AUTOMATED

Countries
Spain
Know more
Chemicals

METHOD FOR THE SEPARATION AND PURIFICATION OF CARBON MONOXIDE FROM GAS MIXTURES USING IONIC LIQUIDS

Countries
Spain
Know more
Health
Chemicals
Food & Agro

COMPOSITION FOR THE REDUCTION OF METABOLIC DECLIVE ASSOCIATED WITH AGING AND/OR THE TREATMENT OF DISORDERS RELATED TO LIPID METABOLISM (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries
Spain
Know more
Get back to patents directory